Available online http://ccforum.com/content/13/5/R159 Open AccessVol 13 No 5Research Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc

REVIEW Corresponding author Spinello Antinori E-mail: [email protected] SARS-CoV-2 pandemic which started in Wuhan, China at the end of December, 2019 has been responsible

Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonatesComparison of the incidence, clinical features and outcomes of

CLINICAL GUIDELINE A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU projectIncidence and outcome of invasive candidiasis in intensive

Recommendations for the management of candidemia in adults in Latin America1 h Revista Iberoamericana de Micología pecial Article ecommendations for the management

The Nebraska Medical Center Guidelines for Management of Invasive Candidiasis Purpose To provide a framework for initial evaluation and management of immunocompetent and

INVASIVE CANDIDIASIS (CAGTA) IFA IgG ENScientific literature support Access to the bibliographic references of INVASIVE CANDIDIASIS (CAGTA) IFA IgG Ref. PCAALG 50 tests INVASIVE

Mycamine, INN-micafungin2 1. NAME OF THE MEDICINAL PRODUCT Mycamine 50 mg powder for concentrate for solution for infusion Mycamine 100 mg powder for concentrate for solution

© Annals of Infection. All rights reserved. Ann Infect 2019;3:3 | http://dx.doi.org/10.21037/aoi.2019.07.02 Candida, the most prevalent hospital-associated fungal pathogen,